University of Saskatchewan COVID-19 vaccine approved for human clinical trials
A COVID-19 vaccine developed by the University of Saskatchewan s Vaccine and Infectious Disease Organization (VIDO) is headed for human clinical trials.
Social Sharing
CBC News ·
Posted: Dec 29, 2020 11:48 AM CT | Last Updated: December 29, 2020
The VIDO-InterVac facility is home to one of Canada s only research facilities with a Level 3 containment lab. (Matthew Garand/CBC)
Governments only buy and distribute vaccines after studying them to make sure they work and are safe. Researcher Alyson Kelvin, pictured here at the University of Saskatchewan’s Vaccine and Infectious Disease Organization, has spent the past 20 years preparing vaccines that could be used to tackle viruses like the coronavirus. (Image credit: Liam Richards/The Canadian Press) 2/ Do the COVID-19 vaccines work? More than 43,000 people were involved in the testing process for the Pfizer-BioNTech vaccine, which is the first COVID-19 vaccine to be approved in Canada. That’s one of the largest groups to ever be involved in testing a vaccine like this.